For those unfamiliar with CME web site BioCritique
www.biocritique.com please check it out. There are diabetes, cardiovascular and primary care forums and many of the NLA thought leaders are faculty members. Important breaking manuscripts are reviewed.
The article is a prepublication in the Journal Menopause
Fascinating data from SWAN discusses HDL-C and atherosclerosis in menopausal women. Supporting 2007 data from The Los Angeles Atherosclerosis Study, it seems the protective effect of HDL may be diminished as women transition in menopause. My conclusion (and please read the entire BioCritique analysis) is that all of the "carved in stone" statements about high HDL-C necessarily being cardioprotective or that raising HDL-C per se with various modalities is always beneficial must be dismissed.
Thomas Dayspring MD, FACP, FNLA, NCMP
Director North Jersey Institute of Menopausal Lipidology
516 Hamburg Turnpike Suite 5
Wayne, N.J. 07470
ldl-p (11)
